Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ(TM) COVID-19 Wastewater Testing Service
PR88353
IRVINE, Calif., March 4 2021 /PRNewswire=KYODO JBN/ --
-- New Service Allows Tracking of Viral Variants and Vaccine Resistance with A
Single Sample
Zymo Research announced today the launch of its Environ(TM) COVID-19 Wastewater
Testing Service(
). This service facilitates daily community-wide monitoring of COVID-19 cases
and variants from a single wastewater sample. Daily case estimates and detected
SARS-CoV-2 variants of concern are provided via a secure digital report.
Photo - https://mma.prnewswire.com/media/1449489/Wastewater_Service.jpg
Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg
The Environ(TM) COVID-19 Wastewater Testing Service uses daily wastewater
samples to provide institutions with the means to monitor COVID-19 variants and
case levels. Participants will be provided with sample collection devices,
enabling daily wastewater sample submission, and materials for secure, pre-paid
overnight shipping. Within 24 hours of each sample submission, users will
receive an electronic report containing their trend and case estimate analysis.
Data pertaining to SARS-CoV-2 variants will be processed weekly. Case estimates
are provided as well as daily concentration trends and the detection of variant
strains of concern, relating to those found in Brazil, the UK, and South
Africa. A Zymo Research Environ™ wastewater scientist guides every step of the
process, from sample collection to interpretation of results.
"COVID-19 variants pose a significant risk to vaccination strategies making
fast, reliable SARS-CoV-2 variant surveillance at scale more critical than ever
before," said Michael Lisek, Project Manager, Environmental Microbiomics at
Zymo Research. "We are grateful for the opportunity to help universities,
public health agencies, and communities with limited testing resources monitor
COVID-19 cases and variants at scale in a way that has not been possible
before."
Institutions of higher education, schools with on-campus housing, nursing
homes, correctional facilities, and hospitals are ideal candidates for
wastewater testing due to the need for focused monitoring of populations at
higher risk for COVID-19. By sampling in wastewater from group-living
situations, organizations can quickly identify COVID-19 outbreaks up to a week
before symptomatic cases appear with the Environ(TM) COVID-19 Wastewater
Testing Service. The data from the service may be used to guide health
strategies for public and private institutions.
As vaccine rollouts continue, the Environ(TM) COVID-19 Wastewater Testing
Service will serve a critical role in controlling the COVID-19 pandemic by
providing insight into case levels and variants present in communities. For
more information and pricing visit Zymo Research's website(
) or contact them via email at environservices@zymoresearch.com.
About Zymo Research Corp.
Zymo Research is a privately owned company that has been serving the scientific
and diagnostics community with state-of-the-art molecular biology tools since
1994. "The Beauty of Science is to Make Things Simple" is their motto, which is
reflected in all of their products, from epigenetics to DNA/RNA purification
technologies. Historically recognized as the leader in epigenetics, Zymo
Research is breaking boundaries with novel solutions for sample collection,
microbiomic measurements, diagnostic devices, and NGS technologies that are
high quality and simple to use. Follow Zymo Research on Facebook(
), LinkedIn(
), Twitter(
), and Instagram(
).
For more information about Zymo Research's COVID-19 products, check out the
following links:
-- Zymo Research Releases Free Software to Streamline COVID-19 Test
Reporting(
)
-- Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit(
)
-- Zymo Research Obtains Emergency Use Authorization from FDA for Their Quick
SARS-CoV-2 rRT-PCR Kit(
)
-- Zymo Research Receives CE IVD Mark for its Quick-DNA/RNA(TM) Viral MagBead
Kit(
)
-- Zymo Research Launches COVID-19 Sequencing Service for the Detection and
Surveillance of Emerging SARS-CoV- Variants(
)
SOURCE: Zymo Research Corp.
CONTACT: Marketing Department, Zymo Research Corp., 949.679.1190,
marketing@zymoresearch.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
